AMBLor® test (IMAGE)
Caption
Applying the test - called AMBLor® - to the standard biopsy of the primary melanoma on its removal, patients who are at low risk of the disease reoccurring or spreading can be identified.
Credit
AMBLo Biosciences & Newcastle University, UK
Usage Restrictions
for use only in conjunction with this story
License
Licensed content